MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Omnicell Inc

Cerrado

SectorSanidad

33.94 -0.56

Resumen

Variación precio

24h

Actual

Mínimo

33.17

Máximo

34.3

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

808.75

56.063

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+70.42% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-767M

1.5B

Apertura anterior

34.5

Cierre anterior

33.94

Noticias sobre sentimiento de mercado

By Acuity

5%

95%

2 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 abr 2026, 23:17 UTC

Ganancias

Samsung Forecasts Record First-Quarter Operating Profit

6 abr 2026, 23:00 UTC

Acciones populares

Stocks to Watch: Health Insurers, Mawson, Owlet

6 abr 2026, 22:13 UTC

Principales Movimientos del Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 abr 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 abr 2026, 17:09 UTC

Principales Movimientos del Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 abr 2026, 16:56 UTC

Noticias de Eventos Importantes

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 abr 2026, 14:47 UTC

Principales Movimientos del Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 abr 2026, 23:58 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 abr 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 abr 2026, 23:36 UTC

Charlas de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 abr 2026, 23:15 UTC

Charlas de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 abr 2026, 22:52 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

6 abr 2026, 22:52 UTC

Charlas de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 abr 2026, 22:14 UTC

Charlas de Mercado

Correction to Live Cattle Futures Article

6 abr 2026, 20:56 UTC

Charlas de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

6 abr 2026, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

6 abr 2026, 19:58 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 abr 2026, 19:58 UTC

Charlas de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 abr 2026, 19:11 UTC

Charlas de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 abr 2026, 19:06 UTC

Charlas de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 abr 2026, 19:03 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

6 abr 2026, 19:03 UTC

Charlas de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 abr 2026, 18:36 UTC

Adquisiciones, fusiones, absorciones

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 abr 2026, 17:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 abr 2026, 17:13 UTC

Adquisiciones, fusiones, absorciones

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 abr 2026, 16:33 UTC

Charlas de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 abr 2026, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

6 abr 2026, 14:59 UTC

Ganancias

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

70.42% repunte

Estimación a 12 Meses

Media 58.2 USD  70.42%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

6

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

2 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat